[01] Industry Report · 2026 Edition

The Pharma Meetings Buyer Report

Inside $1.4B of annual pharma meeting spend.

A benchmarking read on how life-science meeting planners buy — authority, budgets, categories, and geography — drawn from the 2026 Pharma Forum cohort.

0
Pharma-side planners in the 2026 cohort
0%
Hold decision-making or influencing authority
0%
Director-level or above (2026 on-site)
$1.4B
Estimated aggregate annual event spend

[02] Buying Authority

The cohort skews heavily toward signers, not spectators.

Of the 164 planners who disclosed their authority, 67 identified as the final decision-maker and 87 as a direct influencer on vendor selection. Pure implementors are the minority.

Decision maker67
Decision influencer87
Implementor / Executor10

Planners were also asked which decision-maker levels they want to meet with — a signal that vendor-selection conversations are actively on the agenda, not incidental.

[03] Buying Power

Per-event budgets and annual event volume, side by side.

Average budget per event (contract value)

Up to $25k14
$26k–$100k29
$101k–$250k39
$251k–$500k34
$501k–$999k29
$1M+21

Events they manage per year

1–10 events / year35
11–20 events / year28
21–50 events / year30
51+ events / year73

Methodology: budget-band midpoint × events-per-year midpoint, summed across disclosing planners. A conservative view of annual contract value inside this cohort.

[04] Category Demand

Which supplier categories planners are actively researching.

Planners self-reported the categories they want to learn more about. Count reflects the number of planners flagging active interest — a proxy for near-term category demand.

Hotel chains77
Event technology & Software64
Convention and Visit Bureau (CVB)54
Industry associations44
Gifting/Branded Products44
Venue providers44
Destination Management Company (DMC)41
Audio/Visual39
Sustainability37
Meeting Management Services35
Medical Education and Training/Providers27
Entertainment26

[05] Buyer Composition

Who they work for, and where their meetings land.

Planner type on-site · 2026

3rd Party 59%Corporate 39%Association 2%

Company type

Third-party Meetings86
Large Pharma35
Small & Mid-Size Pharma23
Other11
Biotech9
Medical Device / Medtech8
Pre-commercialization1
CRO/CDMO1

Where their meetings happen

USA – Northeast86
USA – Midwest80
USA – West79
USA – Southeast76
EMEA41
Canada39
Mexico29
South America/Central America21

Event types they organize

Other Internal/Corporate Meetings113
Congress/convention/tradeshow106
Other Medical Meetings like Advisory Boards106
Investigator Meetings etc.106
Incentive Meetings69
Product launches68
Speaker programs47

[06] Cohort Turnover

41% of the 2026 cohort was first-time.

Live polling from Pharma Forum 2026 shows a meaningfully refreshed audience year-over-year — the buyer roster is not a static list of returning names.

Asked what they were most looking forward to, planners surfaced a consistent set of operational themes worth tracking as leading indicators for category spend.

Themes planners flagged as top-of-mind

  • 01AI in event planning
  • 02Event technology
  • 03Sustainability
  • 04New pharma trends
  • 05Congress planning
  • 06F&B guidelines
  • 07HCP engagement
  • 08Compliance updates
  • 09Sales & procurement
  • 10Booking windows
  • 11Contracting
  • 12Production support

[06b] Engagement in Practice

What buyer engagement actually looked like on the floor.

The 2026 post-event data quantifies how much planner ↔ supplier contact the cohort generated in a single week — useful context when sizing this channel against other outbound motions.

Source: Pharma Forum 2026 Post-Event Report · Boston, MA · March 22–25, 2026.

0+
Confirmed 1:1 planner ↔ supplier meetings
0+
Buyer-initiated conversations in the event app
0+
Hours of dedicated networking programming
0+
Planners & partners on-site
0+
Supplier organizations already participating
0%
Planners at director level or above

[07] Deal Economics

The compliance framework planners work inside.

Benchmarks from the 2025 Pharma Forum Life Science & Medical Meetings Survey. Meal caps and out-of-office policies define the price envelope for F&B, venue, and hospitality categories.

$50
Avg breakfast cap
$65
Avg lunch cap
$150
Avg dinner cap
$35
Avg breaks cap
65%

of respondents apply event-type-specific meal caps — the pricing rulebook varies by meeting format.

72%

apply out-of-office meal caps in the US — the same policy scaffolding governs off-site programs.

47%

raised their caps year-over-year — a directional signal that premium tiers have room to move.

[08] Size Your Slice

Stop guessing at your addressable slice of the $1.4B.

The interactive dataset lets you cross-tab the 245-planner cohort by category interest, budget band, decision authority, company type, and geography — and watch the count and aggregate spend recompute in real time.

Sample queries →

  • AV & production buyers with ≥$1M annual spend
  • Corporate planners sourcing hotels outside the US
  • Final decision-makers shopping meeting-tech platforms

Why it matters

Every filter narrows to a concrete, nameable buyer segment — the same segments that show up in the room each March. Use it to pressure-test your ICP against real demand before you spend a dollar chasing it.

Open the interactive dataset →

[09] About This Report

Published from the Pharma Forum community.

Compiled by Informa Connect from first-party 2026 attendee data, live event polling, the Pharma Forum 2026 Post-Event Report, and the 2025 Life Science & Medical Meetings Benchmarking Survey.

Looking for ways to reach these buyers in-person at Pharma Forum 2027? Get in touch.